Report Details

Our new study shows you the commercial potential of regenerative treatments

What does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our study lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. It lets you assess projected sales at world market, market segment, product and regional level to 2024. You will see financial results, interviews, trends, opportunities, and revenue predictions.

In our investigation you also see qualitative analyses, news R&D and business developments. Our 240 page report provides 122 tables, charts, and graphs. Read the full transcripts of three exclusive expert opinion interviews from leading industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Dr. Alan Trounson - President, California Institute for Regenerative Medicine (CIRM)
- Professor Francois Berthiaume - Associate Professor of Biomedical Engineering, Rutgers University, New Jersey
- Dr. William Dolphin - CEO, Avita Medical

You will find prospects for submarkets and products

In addition to analyses of the overall world market, you will see revenue forecasting of three world-level submarkets to 2024:
• Stem cell therapy
• Tissue engineered products
• Gene therapy

Also, you will discover how leading products - including Apligraf, Dermagraft, ReCell, Osteocel Plus, Trinity Evolution and Neovasculgen - perform from 2014 to 2024. You will find business research and analysis with individual revenue forecasts and discussions.

What are the prospects in leading regions and countries?

There are many commercial opportunities in developed and developing countries. You discover individual revenue forecasts to 2024 for regions, with discussions of countries:
• US
• Europe
• Asia Pacific - including Japan, China, India, South Korea and Australia
• Rest of the world - including Brazil

This decade, revenues from the Asia-Pacific region will be the fastest-growing worldwide.
Revenues in many countries will multiply many times from 2014 to 2024, our analyses show.

Research and development - potential in this emerging industry

What's happening in the R&D pipeline for translational regenerative medicine? Our study shows developmental trends:
• Diabetes treatments
• Cardiovascular and cardiology treatments
• Cancer therapy
• Ocular (ophthalmological) uses - treating eye diseases
• Wound care
• Treatments for neurological disorders

Discover how science and technology is changing translational regenerative medicine. Our investigation shows you trends and outlooks, exploring matters affecting the sector.

What issues affect the regenerative treatments and industry market?

Our study lets you assess industry trends and outlooks. You will find discussions, including qualitative analyses:
• Tissue engineering - including 3D bioprinting and organ transplants
• Autologous chondrocyte implantation (ACI)
• Haematopoietic stem cell transplantation and other cellular treatments
• Orthobiologics, biomaterials, neuroprotection and nanotechnology
• Gene therapy, including delivery and viral vectors
• Bone marrow material and human embryonic stem cells
• Mesenchymal stem cell technologies
• Skin regeneration, wound repair, cosmetic uses and treating degenerative disorders
• Treatment of leg ulcers, cartilage, livers, hearts and eyes

You will see discussions of technological, commercial, and economic matters, with emphasis on organisations developing technologies.

Leading companies and potential for market growth

This decade, this biotechnology sector will flourish - already

Table Of Contents

1. Executive Summary

1.1 Overview of Findings
1.2 Structure of the Report
1.3 Research and Analysis Methods
1.4 Glossary of Terms in this Report

2. Introduction to Translational Regenerative Medicine

2.1 What is Translational Regenerative Medicine?
2.2 Translational Regenerative Medicine: Market Segmentation
2.2.1 Stem Cell Therapy Classifying Stem Cells by Potency Categories of Stem Cells Autologous versus Allogeneic Stem Cells: Towards Universal Stem Cell Products? Stem Cell Therapeutic Applications
2.2.2 Tissue Engineering
2.2.3 Gene Therapy Harnessing Infectivity: Viral Vectors in Gene Therapy
2.3 Other Areas of Regenerative Medicine
2.3.1 Small Molecules and Proteins - Enhancing Regenerative Medicine
2.3.2 Cosmetic Applications of Regenerative Medicine
2.4 Regulation of Regenerative Medicine
2.4.1 Regulation of Regenerative Medicine Products in Europe
2.4.2 Regulation of Regenerative Medicine Products in the US
2.5 Phases of Clinical Trials
2.6 Scope of this Report
2.6.1 Products Excluded from this Report

3. Regenerative Medicine: World Market 2014-2024

3.1 The World Regenerative Medicine Market in 2012 and 2013
3.2 Leading Regenerative Medicine Products
3.3 Leading Companies in the Regenerative Medicine Market
3.4 World Regenerative Medicine Market: Sales Forecast 2014-2024
3.4.1 Regenerative Medicine Market Segments: Sales Forecasts 2014-2024
3.4.2 Regenerative Medicine: CAGRs by Segment 2014-2024
3.4.3 Changing Market Shares by Segment 2014-2024
3.5 Stem Cell Therapies Lead the Regenerative Medicine Market
3.5.1 Stem Cells Therapy Market: Drivers and Restraints 2014-2024
3.6 Tissue Engineered Products Will Continue Strong Growth
3.6.1 Tissue Engineered Products Market: Drivers and Restraints 2014-2024
3.7 Gene Therapies Show High Growth Potential
3.7.1 Gene Therapy Market: Drivers and Restraints 2014-2024

4. Leading National Markets 2014-2024

4.1 Regional Breakdown of the World Regenerative Medicine Market
4.2 World Regenerative Medicine Market: Regional Forecast 2014-2024
4.2.1 Regenerative Medicine: CAGRs by Regional Market 2014-2024
4.2.2 How Will Regional Market Shares Change to 2024?
4.3 The US Regenerative Medicine Market 2014-2024
4.3.1 US Regenerative Medicine Market: Drivers and Restraints
4.3.2 US Market Overview: The Leading Regenerative Medicine Market Regulation of Regenerative Medicine in the US Embryonic Stem Cell Research Remains Controversial An End to Patents on Human Genes?
4.4 The European Regenerative Medicine Market 2014-2024
4.4.1 European Regenerative Medicine Market: Drivers and Restraints
4.4.2 European Market Overview: A Strong Science Base On the Brink of a Unitary European Patent System Regulation of Regenerative Medicine in Europe European REMEDiE Project A UK Perspective on the Regenerative Medicine Market Developments in the Russian Regenerative Medicine Market
4.5 The Asia-Pacific Regenerative Medicine Market 2014-2024
4.5.1 Asia-Pacific Regenerative Medicine Market: Drivers and Restraints
4.5.2 Asia-Pacific Market Overview: Towards Rapid Commercialisation Japan: Transforming the Regulatory Landscape China: Encouraging Stem Cell RandD India: An Emerging RM Industry South Korea: First to Approve Stem Cell Treatments Australia: Encouraging Translational Regenerative Medicine
4.6 The Regenerative Medicine Market in the Rest of the World 2014-2024
4.6.1 Brazil - An Emerging Market in South America

5. Leading Companies in the Regenerative Medicine Market

5.1 Aastrom Biosciences: Developing Cardiovascular Stem Cell Therapies
5.1.1 Aastrom Biosciences: Clinical Trials
5.1.2 A

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Markets for Drug-Device Combinations

Global Markets for Drug-Device Combinations

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth ...

World Intravenous Immunoglobulin (IVIg) Industry

World Intravenous Immunoglobulin (IVIg) Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million and in Kilograms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, ...

Blood & Organ Bank Lines World Report

Blood & Organ Bank Lines World Report

  • $ 4 609
  • Industry report
  • March 2015
  • by PureData

BLOOD & ORGAN BANK LINES WORLD REPORT The Blood & Organ Bank Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: ...

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.